OpenAI Looks To Replace Thousands Of Junior Bankers

TalkMarkets - Tue, 11/04/2025 - 18:50
OpenAI’s secret Project Mercury employs ex-bankers from JPMorgan, Goldman, and Morgan Stanley to train AI to automate junior banking tasks like financial modeling.

Tesla: Get Out Before The Hype Ends

Seeking Alpha - Tue, 11/04/2025 - 18:47

Ascent Industries outlines path to $120M–$130M revenue through organic growth while achieving 30%+ gross margin

Seeking Alpha - Tue, 11/04/2025 - 18:47

Astera Labs targets Q4 revenue up to $253M while expanding scale-up AI connectivity and optical roadmap

Seeking Alpha - Tue, 11/04/2025 - 18:47

Amgen raises 2025 revenue guidance to $35.8B–$36.6B with 14% volume growth, launches AmgenNow platform

Seeking Alpha - Tue, 11/04/2025 - 18:37

Coterra signals modest capital reduction for 2026 while boosting 2025 production outlook and shareholder returns

Seeking Alpha - Tue, 11/04/2025 - 18:37

Finance of America outlines 20%-25% volume growth and $4.25-$4.75 adjusted EPS for 2026 as digital and AI investments accelerate

Seeking Alpha - Tue, 11/04/2025 - 18:37

Cirrus Logic targets $500M-$560M Q3 revenue and expands AI PC audio reach while driving record Q2 sales

Seeking Alpha - Tue, 11/04/2025 - 18:37

Masimo raises EPS guidance to $5.40–$5.55 while advancing AI-enabled monitoring and Philips partnership

Seeking Alpha - Tue, 11/04/2025 - 18:37

Intel: Don't Be Fooled (Rating Downgrade)

Seeking Alpha - Tue, 11/04/2025 - 18:35

Cooper-Standard: Temporary Ford Disruption Offers A Better Entry Point

Seeking Alpha - Tue, 11/04/2025 - 18:30

Dumbest Reason Not To Short

TalkMarkets - Tue, 11/04/2025 - 18:30
I would love to be short Vistra (VST​​​​​​​). In fact, I shorted it yesterday, but I covered. Why? Because the quote is wrong!

Corcept anticipates $3B–$5B annual hypercortisolism revenue with relacorilant as FDA decisions near

Seeking Alpha - Tue, 11/04/2025 - 18:26

Tesla's $1T Dilemma: A Choice Between Weak Fundamentals And The Musk Premium

Seeking Alpha - Tue, 11/04/2025 - 18:19

Corvus outlines January data readout for soquelitinib extension study as Phase II atopic dermatitis trial set for Q1 2026

Seeking Alpha - Tue, 11/04/2025 - 18:16

Crude oil turns lower on stronger dollar, oversupply worries

Seeking Alpha - Tue, 11/04/2025 - 18:15

AMD: Triple-Play Quarter Justifies Mr. Market's Recent Optimism

Seeking Alpha - Tue, 11/04/2025 - 18:12

Is Paying Down Government Debt Bad For The Economy?

TalkMarkets - Tue, 11/04/2025 - 18:10
Real wealth beats accounting tricks and paydowns aren’t a mechanical path to recession.

Arteris signals 24% ACV plus royalties growth and raises 2025 revenue target amid AI-driven demand

Seeking Alpha - Tue, 11/04/2025 - 18:07

Tempus AI signals sustained 25% genomics growth target through 2028 while achieving first positive adjusted EBITDA

Seeking Alpha - Tue, 11/04/2025 - 18:07

Pages